Reduced pulmonary endothelium-bound angiotensin converting enzyme activity in diabetic rabbits (Q45193064)

10 December 2017

Reduced pulmonary endothelium-bound angiotensin converting enzyme activity in diabetic rabbits (English)

1 reference

10 December 2017

0 references

Laryssa L McCloud

1

1 reference

10 December 2017

James B Parkerson

2

1 reference

10 December 2017

Lihua Zou

3

1 reference

10 December 2017

R N Rao

4

1 reference

10 December 2017

John D Catravas

5

1 reference

10 December 2017

1 May 2004

1 reference

10 December 2017

Vascular Pharmacology

1 reference

10 December 2017

41

1 reference

10 December 2017

4-5

1 reference

10 December 2017

159-165

1 reference

Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins.

10 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Pulmonary function in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Cardiorespiratory effects of continuous i.v. administration of the ACE inhibitor enalaprilat in the critically ill.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Vascular recruitment increases evidence of lung injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Renin-angiotensin system in sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Changes in lung morphologic features and elasticity caused by streptozotocin-induced diabetes mellitus in growing rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Lung volume and distensibility in insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Early pulmonary endothelial enzyme dysfunction after phorbol ester in conscious rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Development of vascular complications in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Assay of pulmonary microvascular endothelial angiotensin-converting enzyme in vivo: comparison of three probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Endothelial ectoenzyme assays estimate perfused capillary surface area in the dog lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Is the lung a 'target organ' in diabetes mellitus?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Lung elasticity in juvenile-onset diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Disturbances of micronutrient and antioxidant status in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Pulmonary complications of type 1 (insulin-dependent) diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Effects of blood flow on lung ACE kinetics: evidence for microvascular recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

A comparison of the microvascular lesions in diabetes mellitus with those in normal aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2004.08.004

10.1016/J.VPH.2004.08.004

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference